Iisrael - heebrea - Ministry of Health

beammed ltd. - רופא - לייזר לטיפול בפרוסטטה מוגדלת/מוקטנת

Iisrael - heebrea - Ministry of Health

beammed ltd. - רופא - מיכשור לטיפולים אסתטיים המבוסס על לייזר ו-fr

Iisrael - heebrea - Ministry of Health

beammed ltd. - כלל האוכלוסיה - בדיקת חוזק עצמות ודיאגנוסטיקה של סטטוס עצם

Iisrael - heebrea - Ministry of Health

abbott medical laboratories ltd, israel - pancreatin - קפסולות - pancreatin 150 mg - multienzymes (lipase, protease etc.) - multienzymes (lipase, protease etc.) - pancreatic exocrine insufficiency.

Iisrael - heebrea - Ministry of Health

abbott medical laboratories ltd, israel - pancreatin - קפסולות - pancreatin 300 mg - multienzymes (lipase, protease etc.) - multienzymes (lipase, protease etc.) - for the treatment of pancreatic exocrine insufficiency.

Iisrael - heebrea - Ministry of Health

trima israel pharmaceutical products maabarot ltd - ox bile extract; pancreatin - דרז'ה - pancreatin 72 mg; ox bile extract 35 mg - multienzymes and acid preparations - multienzymes and acid preparations - regulation of digestive disturbances, indigestion fermentative dyspepsia, gastroenteritis, meteorism, epigastric fullness and post prandial distress.

Iisrael - heebrea - Ministry of Health

boehringer ingelheim israel ltd. - alteplase - אבקה וממס להכנת תמיסה להזרקה\אינפוזיה - alteplase 50 mg/vial - enzymes - acute myocardial infarction in adults for the lysis of thrombi obstructing coronary arteries the improvement of ventricular function and reduction of the incidence of congestive heart failure. pulmonary embolism with hemodynamic deprivation. for fibrinolytic treatment of acute ischaemic stroke. treatment must be started within 3 hours of onset of the stroke symptoms and after prior exclusion of intracranial haemorrhage by means of appropriate imaging techniques.this treatment is restricted to a prescription by aspecialist in neurology.

Iisrael - heebrea - Ministry of Health

boehringer ingelheim israel ltd. - alteplase - אבקה וממס להכנת תמיסה להזרקה\אינפוזיה - alteplase 20 mg/vial - enzymes - acute myocardial infarction: actilyse is indicated for use in the management of acute myocardial infarction (ami) in adults for the lysis of thrombi obstructing coronary arteries, the reduction of infarct size, the improvement of ventricular function, the reduction of the incidence of congestive heart failure and the reduction of mortality associated with ami. treatment should be initiated as soon as possible after the onset of ami symptoms. massive pulmonary embolism with hemodynamic deprivation : actilyse is indicated in the management of acute massive pulmonary embolism (pe) in adults : - for the lysis of acute pulmonary emboli, defined as obstruction of blood flow to a lobe or multiple segments of the lung, and - for the lysis of pulmonary emboli accompanied by unstable hemodynamics e.g. failure to maintain blood pressure without supportive measures. the diagnosis should be confirmed by objective means, such as pulmonary angiography or noninvasive procedures such as lung scanning. for fibrinolytic treatme

Iisrael - heebrea - Ministry of Health

perrigo israel agencies ltd - pancreatin 60.12 mg - gastro resistant pellets - multienzymes (lipase, protease etc.) - pancreatic exocrine insufficiency.

Iisrael - heebrea - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.